What's New

News

2022/11/16
Launch in Japan of Bevacizumab BS for I.V. Infusion 100mg・400mg “CTNK” ,an anti-VEGF humanized monoclonal antibody PDF
PageTop
Our Business
R&D
Corporate Information
Global Netowork
Investor Relations
Sustainability